Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on Feb 15, 2023.
Shortage details
- Status
- Current
- Company
- XGen Pharmaceuticals DJB, Inc.
- Package NDC
- 39822-4200-2
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)
- Initial Posting
- Feb 15, 2023